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Purpose: The present study was designed to examine effects of different mean airway pressure 
(MAP) settings during high-frequency oscillation (HFO) on oxygenation and inﬂ  ammatory 
responses to acute lung injury (ALI) in rabbits.
Methods: Anesthetized rabbits were mechanically ventilated with a conventional mechanical 
ventilation (CMV) mode (tidal volume 6 ml/kg, inspired oxygen fraction [FIo2] of 1.0, respiratory 
rate [RR] of 30/min, positive end-expiratory pressure [PEEP] of 5 cmH2O). ALI was induced by 
intravenous administration of oleic acid (0.08 ml/kg) and the animals were randomly allocated 
to the following three experimental groups; animals (n = 6) ventilated using the same mode 
of CMV, or animals ventilated with standard MAP (MAP 10 cmH2O, n = 7), and high MAP 
(15 cmH2O, n = 6) settings of HFO (Hz 15). The MAP settings were calculated by the inﬂ  ation 
limb of the pressure-volume curve during CMV.
Results: HFO with a high MAP setting signiﬁ  cantly improved the deteriorated oxygenation 
during oleic acid-induced ALI and reduced wet/dry ratios, neutrophil counts and interleukin-8 
concentration in bronchoalveolar lavage ﬂ  uid, compared to those parameters in CMV and 
standard MAP-HFO.
Conclusions: These ﬁ  ndings suggest that only high MAP setting during HFO could contribute to 
decreased lung inﬂ  ammation as well as improved oxygenation during the development of ALI.
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Introduction
Mechanical ventilation remains the main therapeutic strategy for acute lung injury 
(ALI) and acute respiratory distress syndrome (ARDS). However, mechanical 
ventilation may cause further lung injury and may contribute to systemic inﬂ  ammatory 
response due to overdistension during inspiration due to repeated opening and closing 
of alveoli or due to excessive stress at the margins between the aerated and atelectatic 
lung regions.1–5 To avoid ventilator-associated lung injury, current recommendations 
focus on avoiding both alveolar overdistension and cyclic alveolar collapse and 
reexpansion, as well as achieving and maintaining alveolar recruitment.6–8 Based on 
numerous clinical trials, mechanical ventilation using relatively low tidal volumes (VT) 
and adequate levels of positive end-expiratory pressure (PEEP) are recommended for 
managing patients with ARDS requiring mechanical ventilation.8,9
High-frequency oscillation (HFO) is a ventilation strategy employing very high 
respiratory frequencies with extremely low VT.6,10 Conceptually, HFO provides an 
alternative to conventional mechanical ventilation. Despite disappointing results for 
HFO in early clinical trials in adults with ARDS,11–13 there has been increased renewed Journal of Inﬂ  ammation Research 2009:2 22
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interest in the use of HFO as a rescue therapy for adult 
patients with severe ARDS.10,14–17 As discussed by Froese,6 
ventilating pressure during HFO should be kept above the 
lower inﬂ  ection point (LIP) and the peak alveolar pressure 
below the upper inﬂ  ection point (UIP) on the inﬂ  ation limb 
of the pressure-volume curve of the respiratory system. 
During conventional ventilation, this approach has resulted 
in decreased pulmonary and systemic inﬂ  ammatory mediator 
release1 and improved mortality10 when compared with 
ventilatory strategies that were not lung protective.
Oxygenation during HFO is primarily affected by mean 
airway pressure (MAP)18–20 with the initial setting frequently 
based on those being used for conventional ventilation, by 
trial and error adjustment or by the clinical experience of 
the user.11,21,22 Experimental studies have shown that HFO 
with MAP of 6 cmH2O above LIP or 1.5 times LIP resulted 
in a signiﬁ  cant improvement in oxygenation.23,24 However, 
there are no equivalent recommendations about the effects 
of MAP on inﬂ  ammatory parameters and/or developing ALI, 
especially during long-term use of HFO.
The present study investigated the hypothesis that HFO 
with adequate MAP to obtain better oxygenation could also 
attenuate ALI. We evaluated the effect of different MAP 
settings for HFO during ALI/ARDS development on the 
inﬂ  ammatory response to oleic acid-induced lung injury in 
rabbits.
Methods
The following protocol was approved by the Institutional 
Review Board for the Care and Use of Animals at Shinshu 
University. Care and handling of animals were performed 
in accordance with the guidelines published by the National 
Institutes of Health.
Animal preparation
Adult Male New Zealand 24 white rabbits (3.2 ± 0.2 kg; 
mean ± SD) were initially anesthetized using ketamine 
hydrochloride (Sankyo, Tokyo, Japan) (5 mg/kg, intramuscu-
larly), and the right internal jugular artery and external jugular 
vein were then cannulated (Surﬂ  o 18-gauge catheter, Terumo, 
Tokyo, Japan) to monitor mean systemic arterial pressure 
and to obtain blood samples. After the line placement, the 
rabbits were immobilized by an intravenous injection of 
pancuronium bromide (Sankyo) (0.1 mg/kg). A tracheotomy 
was performed aseptically and a 4-mm interior diameter 
uncuffed endotracheal tube (Mallinckrodt, Argyle, NY, 
USA) was inserted and tied in place. Immediately the 
animals were mechanically ventilated in constant-ﬂ  ow, 
volume-controlled mode (Servo 300; Siemens Elema, Lund, 
Sweden) as follows; an inspired oxygen fraction (FIo2) of 1.0, 
initial respiratory rate (RR) of 30 breath/min with a ratio of 
inspiratory to expiratory time (I:E ratio) of 1:2, and supple-
mented with PEEP of 5 cm H2O. Tidal volume was set to 6 
ml/kg body weight immediately after the onset of ventilation. 
We adjusted RR to maintain an arterial carbon dioxide 
partial pressure (PaCO2) between 35 and 45 mmHg while 
measuring the baseline, and ﬁ  xed the RR after oleic acid 
administration. Anesthesia was maintained by continuous 
infusion of propofol (AstraZeneca, Osaka, Japan) (3 mg/kg/h) 
throughout the experimental protocol via a central venous 
catheter. Muscle relaxants were administered in order to 
eliminate spontaneous breathing. Before obtaining baseline 
measurements, we continuously infused lactated Ringer’s 
solution (Veen-F, Kowa, Tokyo, Japan) at an average rate of 
40 ml/h. The animals were placed on a seat under a radiant 
heat lamp to maintain the temperature at 37 °C.
Baseline values for hemodynamic and respiratory 
parameters were obtained after stabilization for at least 
30 min at the ventilatory settings described previously. 
Then lung injury was induced with oleic acid (Wako Pure 
Chemicals, Osaka, Japan) (0.08 ml/kg) slowly injected via 
the central venous catheter before initiating the experimental 
protocol. Thirty minutes after the administration of oleic 
acid, the animals were randomly assigned to one of the 
following three experimental groups receiving either 
conventional mechanical ventilation (CMV) or HFO. 
However, the ﬁ  rst three animals in the CMV group were 
serially used to determine LIP and UIP on the inﬂ  ation 
limb before the HFO experiment. All rabbits were killed 
4 h after the start of oleic acid infusion by injection of an 
overdose of KCL.
Experimental groups and protocol
In the group receiving CMV (CMV group, n = 6), the 
rabbits were sequentially ventilated for 4 h at the settings 
described above. After the establishment of lung injury, 
the static inspiratory pressure–volume (P–V) curve of 
the respiratory system was measured to identify LIP and 
UIP on the inﬂ  ation limb. The LIP was determined as the 
point of intersection between the slopes of the initial ﬂ  at 
and subsequently steep and linear portions of the inﬂ  ation 
limb of the P–V curve. The point of intersection between 
the slopes of the steep, linear, and ﬁ  nal ﬂ  at portions of 
the inﬂ  ation limb identiﬁ  ed the UIP. LIP and UIP were 
determined by the manual application of tangents to the 
corresponding slopes of the P–V curve. The averages Journal of Inﬂ  ammation Research 2009:2 23
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of LIP and UIP were approximately 8 and 16 cm H2O, 
respectively.
HFO groups
Thirty minutes after oleic acid administration, rabbits were 
then switched to ventilation with HFO. Settings of the 
oscillator were as follows: FIo2 of 0.8, bias ﬂ  ow of 30 l/min, 
a frequency of 15 Hz, and the ratio of inspiratory to expira-
tory time (I:E ratio) was 1:2. The pressure amplitude was 
adjusted to maintain a PaCO2 value less than 50 mmHg 
throughout the experimental period. Subsequently, in the 
standard MAP setting group (S-HFO), MAP was set at 
2 cm H2O above the LIP recorded during CMV; 10 cm 
H2O, while in the high MAP setting (H-HFO) group, 
MAP was set at 6 cm H2O above the LIP or 1.5 times the 
LIP, which remained below the UIP; 15 cm H2O. In the 
present study, we used a newly developed HFO ventilator 
(R100; Metran, Saitama, Japan) for adults. Compared to 
previous HFO ventilators with a reciprocating pump, this 
machine has a rotary valve, which can generate a higher 
oscillatory frequency (5–15 Hz) and greater amplitude 
(approximately 100 ml stroke volume at 15 Hz). This 
machine also allows the use of the conventional mode, 
including pressure or volume control modes, and pressure 
supportive ventilation.
Measurements
Arterial blood samples were obtained at 0, 1, 2, 3, and 
4 h after the start of oleic acid administration to determine 
blood gas, blood cell counts. Mean systemic arterial blood 
pressure and central venous pressure were measured with 
low displacement transducers (Statham P50; Gould, Statham, 
Oxnard, CA, USA) referenced and zeroed to mid-chest 
level, and recorded with a recorder (WT-68; Nihon Koden, 
Tokyo, Japan). The zero reference position was not changed 
throughout the experiment. Arterial pH, PaCO2, and partial 
pressure of oxygen in arterial blood (PaO2) were also 
measured using a blood gas monitoring system (ABL-2; 
Radiometer, Copenhagen, Denmark).
Lung wet-dry weight ratio
At the end of the experiment, the thorax was opened and 
the heart and lungs were removed en bloc by observers 
unaware of the nature of the experiment. The left lobe was 
weighed and then dried to a constant weight at 80 °C for 
72 h in an oven. The ratio of wet weight to dry weight 
(W/D weight ratio) was calculated to assess lung tissue 
edema.
Preparation of bronchoalveolar lavage 
ﬂ  uid and measurements
Through the right main bronchus, 20 ml of saline was slowly 
infused and withdrawn. The bronchoalveolar lavage ﬂ  uid 
(BALF) was analyzed for cell count and cell differentiation. 
A cytocentrifuged preparation (Cytospin 2; Shandon 
Southern Products, Runcorn, UK) of the BALF was stained 
with Wright–Giemsa for cell differentiation. The cells in 
the ﬂ  uid were counted with a counter (Sysmex F-520) and 
the Burker–Turk method. The concentration of interleukin 
8 (IL-8) in BALF was then measured by ELISA. The assay of 
IL-8 was done using the human ELISA kit that cross-reacts 
to rabbit IL-8, using recombinant rabbit IL-8 for the standard 
concentration curve.
Statistical analysis
Experimental data are expressed as mean ± SD, unless stated 
otherwise. A p value of 0.05 was considered signiﬁ  cant. 
Two-way analysis of variance (ANOVA) was used to analyze 
differences between the ventilatory settings. Ryan’s post 
hoc analysis was performed if the global F test indicated 
signiﬁ  cance (p  0.05).
Results
Gas exchange and hemodynamics
Gas exchange and systemic artery pressure at various 
ventilator settings are shown in Figures 1 and 2. There were 
no signiﬁ  cant differences in baseline arterial blood gas analy-
sis and systemic artery pressure among the groups. P/F ratio 
after oleic acid administration was signiﬁ  cantly decreased 
within 30 min and sustained during the experiment in 
both the CMV and S-HFO groups. The P/F ratios of animals 
in the CMV and S-HFO group were signiﬁ  cantly lower than 
their respective baseline values over the remaining period of 
ventilation (Figure 1A). The P/F ratio of animals in H-HFO 
group was signiﬁ  cantly decreased from the baseline at the 
ﬁ  rst 0.5 h after oleic acid administration, but after switching 
from CMV to H-HFO the P/F values increased and remained 
stable. These changes resulted in a signiﬁ  cantly higher P/F 
ratio in the H-HFO group compared with those in CMV and 
S-HFO group between 1.5 and 4 h.
After oleic acid administration, the values of PaCO2 
tended to rise throughout experiments in animals treated 
with CMV. However, PaCO2 did not change after switching 
from CMV to either S or H-HFO (30 min after oleic acid 
injection). For animals in the H-HFO group, PaCO2 values 
tended to decrease over time (Figure 1B). Statistical Journal of Inﬂ  ammation Research 2009:2 24
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comparisons among the groups demonstrated that animals 
in H-HFO group had signiﬁ  cantly lower mean PaCO2 values 
compared with those in the CMV group from 2.5 to 3 h.
Values of mean systemic artery pressure increased 
signiﬁ  cantly in the CMV group between 2 and 2.5 h compared 
with baseline values (Figure 2). Comparisons of mean 
systemic artery pressure among the three groups, however, did 
not show any signiﬁ  cant differences at any time point. Central 
venous pressure values remained unchanged from the baseline 
values throughout the experiment (data not shown).
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Figure 1 Time courses in PaO2/FiO2 (P/F) ratio A) and PaCO2 B) in rabbits of each group after oleic acid administration. CMV group (dashed line and closed circle): animals 
were instilled with oleic acid and ventilated with conventional ventilation. S-HFO (line and open circle): animals were instilled with oleic acid and ventilated with HFO set to the 
standard mean airway pressure, H-HFO (line and closed triangle): animals were instilled with oleic acid and ventilated with HFO set to a high mean airway pressure.
Notes: Values are means ± SEM. *P  0.05, compared with baseline. #P  0.05, compared with other groups.
Abbreviations: CMV, conventional mechanical ventilation; FiO2, fraction of inspired oxygen; HFO, high-frequency oscillation; H-HFO, high-frequency oscillation set to a high 
mean airway pressure; PaO2, partial pressure of oxygen in arterial blood; PaCO2, partial pressure of carbon dioxide in arterial blood; S-HFO, high-frequency oscillation set to 
the standard mean airway pressure.
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Figure 2 Time courses in mean systemic artery pressure in rabbits of each group after oleic acid administration. CMV group (dashed line and closed circle): animals were 
instilled with oleic acid and ventilated by conventional ventilation. S-HFO (line and open circle): animals were instilled with oleic acid and ventilated with HFO set to the standard 
mean airway pressure, H-HFO (line and closed triangle): animals were instilled with oleic acid and ventilated with HFO set to a high mean airway pressure.
Notes: Values are means ± SEM. *P  0.05, compared with baseline. #P  0.05, compared with other groups.
Abbreviations: CMV, conventional mechanical ventilation; HFO, high-frequency oscillation; H-HFO, high-frequency oscillation set to a high mean airway pressure; S-HFO, 
high-frequency oscillation set to the standard mean airway pressure; SEM, standard error of mean.Journal of Inﬂ  ammation Research 2009:2 25
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Accumulation of edema ﬂ  uid in the lung
The W/D ratio in rabbits treated with CMV was signiﬁ  cantly 
increased compared with that in untreated normal rabbits 
(n = 5). The lung W/D weight ratio signiﬁ  cantly reduced 
in the H-HFO group compared with that in the CMV group 
(5.27 ± 0.36 versus 6.74 ± 0.83, p  0.05) (Figure 3). 
However, there were no signiﬁ  cant differences in the lung 
W/D weight ratio between in CMV and S-HFO group.
Analysis of BALF
The recovery rates of BALF were greater than 90% in all 
groups and there were no signiﬁ  cant differences in the 
recovery rates among the groups. Analysis of concentration 
of total protein, total cell counts, the neutrophil counts and 
IL-8 concentration in BALF were shown in Table 1. Total 
numbers of nuclear cells and neutrophils in BALF of CMV 
group were signiﬁ  cantly higher than those of the normal 
control groups. H-HFO treatment signiﬁ  cantly decreased 
oleic acid -induced increase in the neutrophil counts in the 
lung. H-HFO also signiﬁ  cantly decreased the total protein 
concentration compared with that in CMV group, whereas 
there were no significant differences in total cell and 
neutrophil counts and protein concentration between the 
CMV and S-HFO groups. Likewise, IL-8 concentration in 
BALF was signiﬁ  cantly suppressed to 164.4 ± 76.5 ng/ml 
in H-HFO group in comparison to that in the CMV group 
(405.7 ± 147.8 ng/ml, p  0.05).
Histological changes
Histological examination demonstrated thickening, damage 
of the alveolar wall and infiltration of neutrophils and 
accumulation of erythrocytes in the alveolar spaces of rabbit 
lung treated with oleic acid (Figure 4B). HFO ventilation, 
especially set to a high MAP, attenuated these histological 
changes induced by oleic acid. Furthermore, hyaline 
membrane formation was also detected in the CMV after 
oleic acid administration, but less in S-HFO (Figure 4C) and 
not in H-HFO (Figure 4D) groups.
Discussion
We have shown in rabbits that HFO with a relatively higher 
MAP reduces inﬂ  ammatory response to oleic acid-induced 
lung injury as well as maintaining better oxygenation 
compared with those under CMV and standard MAP setting 
in HFO. In addition, even the higher MAP setting during 
HFO during ALI did not show any adverse effects on 
cardiovascular compression. These data suggest that HFO 
with a relatively higher MAP is useful for preventing the 
exacerbation of ALI/ARDS.
Several experimental and clinical studies demonstrated that 
a higher MAP during HFO can promote better oxygenation. 
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Figure 3 Lung wet to dry weight ratios in all groups. CMV: animals were instilled with oleic acid and ventilated with conventional ventilation. S-HFO: animals were instilled 
with oleic acid and ventilated with HFO set to the standard mean airway pressure, H-HFOV: animals were instilled with oleic acid and ventilated with HFO set to a high mean 
airway pressure. Control; no-treatment group.
Notes: Values are expressed as mean ± SEM. #P  0.05, compared with other groups.
Abbreviations: CMV, conventional mechanical ventilation; HFO, high-frequency oscillation; H-HFO, high-frequency oscillation set to a high mean airway pressure; H-HFOV, high-
frequency oscillation ventilation set to a high mean airway pressure; S-HFO, high-frequency oscillation set to the standard mean airway pressure; SEM, standard error of mean.Journal of Inﬂ  ammation Research 2009:2 26
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Luecke and colleagues evaluated the use of the P-V curve to 
set MAP in swine with lavage injury and reported that gas 
exchange and hemodynamic data were best at 1.5 × LIP on 
the inﬂ  ation limb of the P–V curve.23 Goddon and colleagues 
also found that HFO with MAP of LIP + 6 cmH2O provided 
the best improvement in oxygenation in an ALI experiment.24 
In the present study, LIP was assessed as 8.0 cm H2O in the 
obtained P–V curve during CMV ventilation. Thus, the higher 
MAP setting of 15 cm H2O during HFO in the present study 
is identical to the settings described in other studies. In other 
words, our data suggest that the ideal MAP setting for better 
oxygenation during HFO is also essential for preventing the 
development of ALI.
Although our ﬁ  ndings are consistent with those of other 
studies indicating that HFO provides preventive ventilation 
for ALI,25–27 only HFO with a higher MAP could achieve a 
signiﬁ  cantly lower inﬂ  ammatory response during developing 
ALI. Inﬂ  ammatory parameters during HFO with a standard 
Table 1 Analysis of BALF
CMV S-HFO H-HFO Control
Total protein (g/dl) 1.71 ± 0.40 1.58 ± 0.23 1.03 ± 0.25* 0.90 ± 0.1*
Total cell count (×104) 55.8 ± 55.0 25.0 ± 6.1 22.5 ± 14.4 5.0 ± 0.1*
Neutrophil (%) 47.9 ± 22.9 26.3 ± 15.8 18.0 ± 11.8* 0.9 ± 0.2*
IL-8 (ng/ml) 405.7 ± 147.8 280.6 ± 128.5 164.4 ± 76.5* 42.4 ± 4.4*
Notes: Data are expressed as mean ± SD. *P  0.05 versus CMV.
Abbreviations: BALF, bronchoalveolar lavage ﬂ  uid; CMV, conventional mechanical ventilation; H-HFO, high-frequency oscillation set to a high mean airway pressure; IL, inter-
leukin; S-HFO, high-frequency oscillation set to the standard mean airway pressure.
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Figure 4 Photomicrographs showing the light microscopic appearance of lung tissue in each group. A) normal control, B) CMV group, C) S-HFO group, D) H-HFO group. 
Magniﬁ  cation x 200. In the CMV group after oleic acid administration, note the congested alveolar walls, alveolar edema, hyaline membranes with alveolar wall disruption, 
and the presence of numerous neutrophils and red blood cells in the alveolar spaces. In the H-HFOV group after oleic acid administration, note the presence of only a few 
neutrophils and red blood cells in the air spaces, the lack of alveolar edema and hyaline membranes and the intact alveolar walls.
Abbreviations: CMV, conventional mechanical ventilation; HFO, high-frequency oscillation; H-HFO, high-frequency oscillation set to a high mean airway pressure; H-HFOV, 
high-frequency oscillation ventilation set to a high mean airway pressure; S-HFO, high-frequency oscillation set to the standard mean airway pressure.Journal of Inﬂ  ammation Research 2009:2 27
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MAP setting including neutrophil accumulation, protein leak-
age, and IL-8 production were not signiﬁ  cantly different from 
those during CMV. In addition, the deteriorated oxygenation 
and lung edema (W/D ratio) after oleic acid administration 
were also similar between standard MAP setting in HFO 
and CMV. These data and our present ﬁ  nding suggest that 
preventive effects against ALI are strongly depended on 
the MAP setting of HFO. On the other hand, Meyer and 
colleagues compared the effects of different frequencies of 
HFO on a surfactant-depleted rabbit model.28 They demon-
strated that 15 Hz HFO ventilation yielded a lower neutrophil 
accumulation in the lung, compared with that at 5 Hz HFO,28 
but blood gas analysis and histological damage scores after 
ALI did not signiﬁ  cantly differ between 5 and 15 Hz HFO. 
Thus, MAP setting, relative to frequency, during HFO is an 
important strategy to protect further lung damage during ALI. 
Our ﬁ  ndings conﬁ  rmed the higher MAP setting in HFO to be 
useful against ALI. However, it is still unclear that the present 
ﬁ  ndings obtained by higher MAP plus 15 Hz reﬂ  ected the best 
clinical usefulness of HFO, because Meyer and colleagues 
showed an increased neutrophil inﬁ  ltration in 5 Hz relative 
to 15 Hz HFO.28 In addition, recent clinical implications have 
indicated that HFO with a reduced frequency is useful to 
maintain normocapnea, by increasing minute ventilation.12–16 
Thus, further studies including various experimental models 
are needed to precisely identify the optimal combination, 
including the frequency and MAP setting for HFO.
Several studies have shown that increasing MAP did not 
further increase oxygenation.20,23,24 In addition, HFO with 
higher MAP setting can decrease venous return of systemic 
circulation due to overdistention of the alveoli, which may 
decrease cardiac output and oxygen delivery.15,20,24,29 The net 
effects of high MAP and decreased cardiac output may lead 
to compression of the pulmonary capillaries and increased 
pulmonary vascular resistance.29 In the present study, at least, 
a higher MAP setting during HFO did not reduce systemic 
artery pressure or increase venous pressure. However, these 
hemodynamic compromises should be minimized for a clinical 
application of HFO, especially with high MAP setting.
There is a limitation in the present study. We compared 
the two different MAP settings of a given and constant level 
for 4 h. In addition, although we selected a low tidal (6 ml/kg) 
volume in CMV, PEEP setting (5 cm H2O) and RR were also 
constant throughout the experiment. Thus, the CMV mode 
itself was inadequate for referential control ventilation. 
However, a higher PEEP employed in CMV could increase 
airway pressure and could contribute to higher adopted 
MAP when switched to HFO. Thus, further experiments and 
evaluations focusing on the inﬂ  ammatory response during 
developing ALI between various PEEP levels of CMV and 
the adopting MAP settings of HFOV will be needed.
In conclusion, we demonstrated in rabbits that HFO 
with a MAP of approximately 1.5 × LIP (6 cmH2O above 
LIP) could reduce the pulmonary inﬂ  ammatory response 
to oleic acid-induced lung injury, but HFO with a standard 
MAP setting could not. Only HFO with an adequately high 
MAP appears to provide greater lung protection against the 
progression of oleic acid-induced lung injury, as well as 
maintaining better oxygenation.
Disclosure
The authors report no conﬂ  icts of interest in this work.
References
  1.  Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation 
on inﬂ  ammatory mediators in patients with acute respiratory distress 
syndrome: a randomized controlled trail. JAMA. 1999;282:54–61.
 2.  Chiumello D, Pristine G, Slustky AS. Mechanical ventilation affects 
local and systemic cytokines in an animal model of acute respiratory 
distress syndrome. Am J Respir Crit Care Med. 1999;160:109–116.
  3.  Ware LB, Matthay MA. Medical progress: the acute respiratory distress 
syndrome. N Engl J Med. 2000:342:1334–1349.
  4.  Ricard JD, Dreyfuss D, Saumon G. Ventilator-induced lung injury. Eur 
Respir J. 2000;42:2s–9s.
 5. Frank JA, Matthay MA. Science review: mechanisms of ventilator-
induced injury. Crit Care. 2003;7:385–390.
 6. Froese AB. High frequency ventilation for adult respiratory distress 
syndrome: let’s get it right this time! Crit Care Med. 1997;25:906–908.
  7.  Marini JJ. Recruitment maneuvers to achieve an “open lung” – whether 
and how? Crit Care Med. 2001;29:1647–1648.
 8. Ventilation with lower tidal volumes as compared with traditional 
tidal volumes for acute lung injury and the acute respiratory distress 
syndrome. The Acute Respiratory Distress Syndrome Network. N Engl 
J Med. 2000;342:1301–1308.
 9.  Amato MB, Barbas CS, Medeiros DM, et al. Effects of a protective-
ventilation strategy on mortality in the acute respiratory distress syn-
drome. N Engl J Med. 1998;338:347–354.
10.  Kirshman JA, Brower RG. High-frequency ventilation for acute lung 
injury and ARDS. Chest. 2000:118:795–807.
11. Mehta S, Lapinsky SE, Hallatt DC, et al. Prospective trial of high-
frequency oscillation in adults with acute respiratory distress syndrome. 
Crit Care Med. 2001;29:1360–1369.
12.  Fort P, Farmer C, Westerman J, et al. High-frequency oscillatory ven-
tilation for adult respiratory syndrome – a pilot study. Crit Care Med. 
1997;25:937–947.
13.  Andersen FA, Guttormsen AB, Flaatten HK. High frequency oscillatory 
ventilation in adult patients with acute respiratory distress syndrome – a 
retrospective study. Acta Anaesthesiol Scand. 2002;46:1082–1088.
14. Ritacca FV, Stewart TE. Clinical review: high-frequency oscillatory 
ventilation in adults – a review of the literature and practical 
applications. Crit Care. 2003;7:387–390.
15.  Derdak S, Mehta S, Stewart TE, et al. High-frequency oscillatory 
ventilation for acute respiratory distress syndrome in adults. A randomized 
controlled trial. Am J Respir Crit Care Med. 2002;166:801–808.
16.  Mehta S, Granton J, MacDonald RJ, et al. High-frequency oscillatory ven-
tilation in adults: the Toronto experience. Chest. 2004;126:518–527.
17.  Nagano O, Fuhii H, Morimatsu H, et al. An adult with ARDS managed 
with high-frequency oscillatory ventilation and prone position. J Anesth. 
2002;16:75–78.Journal of Inﬂ  ammation Research 2009:2 28
Ono et al
18. Froese AB, McCulloch PR, Sugiura M, Vaclavik S, Possamyer F, 
Moller F. Optimizing alveolar expansion prolongs the effectiveness of 
exogenous surfactant therapy in adult rabbits. Am J Respir Crit Care 
Med. 1993;148:569–577.
19.  Rosenberg RB, Brone CW, Peters KJ, Anglin KL. High-frequency ventila-
tion for acute pediatric respiratory failure. Chest. 1993;104:1216–1221.
20. Nakagawa R, Koizumi T, Ono K, et al. Cardiovascular responses to 
high-frequency oscillatory ventilation during acute lung injury in sheep. 
J Anesth. 2007;21:340–347.
21. Arnold JH, Hanson JA, Toro-Figuero LO, Gutierrez J, Berens RJ, 
Anglin DL. Prospective, randomized comparison of high-frequency 
oscillatory ventilation and conventional mechanical ventilation in 
pediatric respiratory failure. Crit Care Med. 1994;22:1530–1539.
22.  Plavka R, Kopecky P, Sebron V, Svihovec P, Zlatohlavkova B, Janus V. 
A prospective randomized comparison of conventional mechanical 
ventilation and very high frequency oscillatory ventilation in extremely 
premature newborns with respiratory distress syndrome. Intensive Care 
Med. 1999;25:68–75.
23.  Luecke T, Meinhardt JP, Herrmann P, Weisser G, Pelosi P, Quintel M. 
Setting mean airway pressure during high-frequency oscillatory ven-
tilation according to the static pressure–volume curve in surfactant-
deﬁ  cient lung injury: a computed tomography study. Anesthesiology. 
2003;99:1313–1322.
24. Goddon S, Fujino Y, Hromi JM, Kacmarek RM. Optimal mean 
airway pressure during high-frequency oscillation. Anesthesiology. 
2001;94:862–869.
25.  Nakagawa R, Koizumi T, Ono K, Yoshikawa S, Tsushima K, Otagiri T. 
Effects of high frequency oscillatory ventilation on oleic acid-induced 
lung injury in sheep. Lung. 2008;186:225–232.
26. Imai Y, Nakagawa S, Ito Y, Kawano T, Slutsky AS, Miyasaka K. 
Comparison of lung protection strategies using conventional and 
high-frequency oscillatory ventilation. J Appl Physiol. 2001;91: 
1836–1844.
27.  Kerr CL, Veldhuizen RAW, Lewis JF. Effects of high-frequency oscil-
lation on endogenous surfactant in an acute lung injury model. Am J 
Respir Crit Care Med. 2001;164:237–242.
28. Meyer J, Cox PN, McKerlie C, Bienzle D. Protective strategies of 
high-frequency oscillatory ventilation in a rabbit model. Pediatr Res. 
2006;60:401–406.
29.  Traverse JH, Korvenranta H, Adams EM, Goldthwait DA, Carlo WA. 
Impairment of hemodynamics with increasing mean airway pres-
sure during high-frequency oscillatory ventilation. Pediatr Res. 
1988;23:628–631.